Price of generic advair?

Generic Advair: What You Need to Know About Pricing and Availability

The price of generic Advair, also known as fluticasone and sulfameter, can vary depending on the country, pharmacy, and type of dosage.

Why is there still no generic alternative?

Advair is a complex medication composed of two active ingredients: fluticasone, a corticosteroid, and salmeterol, a long-acting beta-agonist. The patent for generic Advair expired in 2019, but many manufacturers have encountered challenges in creating a bioequivalent version that meets the required regulatory standards [1].

When can we expect a generic alternative?

Several pharmaceutical companies, including Glenmark, Mylan, and Sandoz, have filed ANDAs (Abbreviated New Drug Applications) with the FDA to market generic versions of Advair. However, the approval process has been delayed due to the complexity of the drug and the need for thorough bioequivalence studies [2].

What is the current pricing scenario?

Due to the patent disputes and lack of generic availability, Advair prices remain high in the United States. According to a report by DrugPatentWatch.com, the branded Advair Diskus currently costs around $500-$600 for a 3-canister pack, and this can be reduced through insurance discounts [3].

Are there biosimilars on the horizon?

Biosimilars, biologically equivalent versions of complex biologics, are not directly comparable to traditional small molecule generics. However, there are biosimilars for some components of the Advair combination (e.g., beclomethasone dipropionate, a corticosteroid in a different formulation). It's unclear how and when biosimilars might influence the cost of the entire Advair combination.

Sources:
[1] DrugPatentWatch.com. (n.d.). Advair (fluticasone and salmeterol) Patent Expiration.
[2] FDA. (2023). ANDAs and Biosimilars: Overview.
[3] DrugPatentWatch.com. (2023). Advair (fluticasone and salmeterol) Average Cost.